An unusual case of ventricular arrhythmia is reported with electrocardiograms showing complete attacks of ventricular tachycardia, ventricular flutter and ventricular fibrillation. The etiology is unknown. Large doses of quinidine, to the point of toxicity, seemed to halt the arrhythmia but did not prevent its recurrence. Ephedrine was given with resulting immediate improvement and no recurrence of the arrhythmia. It is suggested that ephedrine may be of value in treating Stokes-Adams attacks due to ventricular arrhythmia in which there is no heart block but an underlying bradyeardia.
IN recent years it has been pointed out that the classic Stokes-Adams syndrome of unconsciousness is not produced solely by periods of ventricular asystole occurring in patients with complete heart block;" 2, 3 recurrent attacks of loss of consciousness may be due not only to ventricular standstill, but also to ventricular tachycardia, ventricular fibrillation, or all three disturbances occurring in varying sequences. There are few reports of recurrent syncope from ventricular fibrillation without heart block.4 5' 6 The number of these in the literature is still very few, but it is apparent that heart block is not necessarily present in these cases and the widest concept of the syndrome should be syncope due to any ventricular arrhythmia.
The following case of a ventricular arrhythmia is reported because of several unusual features. The patient was observed during numerous spontaneous attacks of ventricular tachycardia and fibrillation with accompanying attacks of syncope. The etiology of the arrhythmia and the nature of the underlying heart disease, if any, are obscure. Electrocardiograms taken between attacks show a long Q-T interval, the cause of which is unexplained. Large doses of quinidine to the point of toxicity seemed to halt the arrhythmia, but did not prevent its recurrence. The myocardium degenerated and a fatal outcome seemed inevita-From the Graduate Hospital and Graduate School of Medicine of the University of Pennsylvania. 585 ble until ephedrine was administered by mouth with resulting or coincident change to normal sinus rhythm and no recurrence of the arrhythmia.
CASE REPORT A white woman, age 53, was admitted to The Graduate Hospital on Dec. 1, 1949 , with a history of two attacks of syncope and palpitation in the preceding 36 hours. She had been in good health with no history of cardiovascular symptoms until 9:30 a.m. the preceding day when she suddenly noticed a palpitation in her chest and felt faint and apparently lost consciousness for a few moments. When seen within an hour she felt weak, but appeared entirely normal. Physical examination was negative. The heart rate was 76 per minute and the rhythm was regular. Blood pressure was 120/80. She was started on quinidine sulfate, 180 mg. every four hours. About 11 a.m. the next day she had another attack after which she was admitted to the hospital. A third attack at 7 p.m. was witnessed by the hospital staff and had the following features: She complained briefly of palpitation in chest, suddenly lost consciousness and developed stertorous breathing, followed in a short time by apnea. She became pale; soon a dusky cyanosis developed. With a restoration of normal rhythm there was a rapid return to a normal state. During the seizure the apical beat was chaotic, very rapid, or absent; the peripheral pulse was absent. This was the pattern of subsequent attacks which lasted from a few seconds to one or two minutes. In the ensuing 10 days these episodes recurred with varying frequency.
Past history was negative for any significant illness. Physical examination revealed a well-developed, well-nourished woman whose complete examination was negative. The heart was normal in Circulation, Volume , | l l ! | I l I I ; : : : A ; r | i i l _ E l l i i i i i { i l L i * l i l l i l l { i I l l T i m + r i i , _ _ _ . _ . l l M l l l M l w T C R . . w B i l i l I 1 . D.
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, , , § , t , @ , 8 e t g , , . § e . . . t . , e t R . Y + * I * } -: e * -I 2 2size, rhythm was regular except during the attacks described above. Blood pressure was 140/80 on admission and usually 120/80. Laboratory studies were normal. figure 1 . The striking feature is the long Q-T interval. Figure 2 shows the first attack which we were able to record graphically.
As soon as the type of arrhythmia was determined to be ventricular tachyeaidia she was given quinidine gluconate,8 0.6 Gm. intramuscularly every two hours.
FI(G. 2. Tracing taken at 7:45 p.m. Dec. 1, 1949 showing attack before quinidine was started. (A) Note the normal sinus rhythm, the long Q-T interval, and the frequent prematurc beats which occur just after the T waves at the so-called "supernormal" time in the cycle. (B) Ventricular and nodal tachycardia, and the termination of the attack.
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Within 15 minutes after quinidine was started she had two short attacks, following which there were no seizures that day. Sedation was given for restlessness and apprehension.
The type of arrhythmia appeared to be ventricular tachycardia; later attacks showed ventricular fibril-quinidine intravenously in doses of 60 to 180 mg. to terminate the alarming immediate episode. Attempts to decrease the dose of quinidine were met with recurrence of the attacks each time. A total of 64.4 Gm. of quinidine were given in the 10-day peliod. On this dosage she developed a blood pres- Figure 3 is an example of a complete attack which was recorded graphically. The cause of the whole picture was obscure.
Large doses of quinidine were given intramuscularly to prevent and to treat attacks. Every one to three hours she received 0.6 Gm. of quinidine gluconate intramuscularly or quinidine sulfate by mouth in addition. During severe attacks she received sure of 80/60, urinary retention due to loss of bladder tone, deafness, tinnitus, abdominal distention, mental confusion and a diffuse erythematous skin rash.
On December 10, in spite of the toxic doses of quinidine, she continued to have short attacks. As the day progressed she gradually became worse. A heavy substernal distress developed, dyspnea became more evident, and she became slightly cyanotic. Bilateral dullness developed over the lower 587 VENTRICULAR ARRHYTHMIA AND STOKES ADAMS SYNDROME lobes of both lungs; the heart was larger by percussion. An x-ray film of the chest, made at the bedside, showed enlargement of the heart and a bilateral diffuse density of the lung fields which ''could be due to either pulmonary congestion from heart failure or a diffuse pneumonitis."
It appeared obvious that a fatal outcome was imminent. At 10 p.m. the following changes in therapy were made: Quinidine was stopped. Ephedrine sulfate, 23 mg. by mouth every three hours, was started. Aureomycin in full therapeutic doses was given in view of a possible developing pneumonitis and also in view of the possibility she may have had a myocarditis of unknown or virus etiology which might be benefited by this antibiotic. A mercurial diuretic was given intramuscularly in view of the pulmonary congestion, but no diuresis resulted.
After these changes in medication there were no more attacks. During the next day she gradually improved. An electrocardiogram showed a normal sinus rhythm with an occasional ventricular premature beat. The heart rate increased to about 90 per minute. The dose of ephedrine was decreased to 23 mg. every four hours. The second day she had no complaints. Pulmonary symptoms and signs disappeared. Bladder tone improved and she voided normally. All signs of quinidine toxicity disappeared. A low grade temperature of 99 to 100 which had developed in the preceding three days returned to normal. Her mental confusion cleared completely.
The subsequent course was uneventful except for a few minor details. The multiple quinidine injections had proved very irritating. She developed several sterile abscesses and sloughs deep in the buttocks which took about three months to heal. Occasional premature contractions persisted throughout her hospital course. She was very apprehensive of these and was very slow to resume much physical activity.
Aureomycin was stopped after 17 days. Ephedrine was decreased to 23 mg. every six, then eight hours, and stopped after 30 days. She was discharged from the hospital 61 days after admission. After several months of very limited activity due to her fear of palpitation, she gradually resumed normal life, and to date has been following a routine life of mild exertion. Six months after her discharge from the hospital an electrocardiogram showed no abnormality except low voltage of the T waves in all leads; the Q-T interval was normal. Physical examination revealed no cardiac abnormalities. She is still very heart conscious and states there is an occasional palpitation, about two to five times a day. No cardiac medication is being taken.
DISCUSSION
A myocarditis of unknown etiology could presumably have caused the disturbances which were present. Conceivably this condi-tion could have produced the striking and unexplained lengthening of the Q-T intervals, a finding which Gittleman and co-workers7 found in 51 to 89.3 per cent (depending upon the formula used) of 51 cases of proved acute myocarditis. Though we cannot entirely dismiss the possibility, we strongly doubt the existence of acute myocarditis since there was nothing that went with an infectious condition until quinidine had produced severe toxic effects and severe heart failure had developed. The disappearance of the low grade temperature (99 to 100 F.) which then developed as well as all other unfavorable signs and symptoms with the ending of the disappearances of rhythm seemed to be more rapid than would have been likely had an active myocarditis been present. No electrolyte disturbance could be found. We, therefore, could not demonstrate definite evidence of organic heart disease.
The cause of the Q-T interval prolongation is unknown in this case. Bellet9 in a recent communication, to be published, analyzing 168 cases associated with Q-T prolongation, lists 26 causes. It is evident that the prolonged Q-T interval was of no help in determining the etiology.
The type of arrhythmia during an attack consisted of runs of ventricular tachycardia, a prefibrillary or flutter-type of ventricular tachycardia, and ventricular fibrillation. At no time did she have ventricular asystole. The syncopal attacks during arrhythmia were indistinguishable from those one sees in syncope due to heart block. Therefore, we would include this case in the group of Stokes-Adams seizures due to ventricular arrhythmias other than asystole in complete heart block. We would emphasize, with others, that Stokes-Adams seizures occur in patients with ventricular arrhythmias other than heart block and ventricular asystole.
Quinidine has long been the drug of choice in treating paroxysmal ventricular tachyeardia.Y0 11, 12 Recently, procaine amide (Pronestyl) has been used quite successfully and will probably supplant quinidine as the most effective drug.'3
The treatment of paroxysmal ventricular 588 DONALD A. I)UPLER fibrillation is much less definite. There is a difference of opinion concerning the value of quinidine. '4-19 In this case, large doses of quinidine at first seemed to prevent attacks, and when the dose was decreased the arrhythmia recurred. Increasingly large doses to the point of intolerable toxicity did not prevent recurrent attacks. We have found no report in the literature of such a ventricular arrhythmia without heart block which was treated with such large doses of quinidine.
Intravenous morphine and intravenous procaine were of no value in this patient. Procaine amide was not available; its value would have been of great interest.
Ephedrine sulfate was decided upon with the hope of increasing the normal heart rate and thereby increasing the total duration of the refractory state of the ventricular muscle. The basic rhythm between attacks was a normal sinus bradyeardia with premature contractions of ventricular or nodal origin. This suggested a vulnerable state of the conduction system and ventricular muscle which predisposed to the arrhythmia. This is in accord with the suggestion of Sprague and Davis'7 that the development of a generalized refractory state of the ventricular muscle following contraction is responsible for the prevention of re-entrant beats and finally fibrillation. It has been shown by Wiggers20 that the period of late systole is a vulnerable period and, in order to initiate fibrillationi experimentally, an electric or noxious influence with a "fibrillary threshold" must be applied during that period in late systole at which time the muscle has passed out of the refractory phase.
The above two considerations are illustrated by our patient in the rhythm just before the attack started. Note the premature beats came after the T wave which terminated the long Q-T interval. This is the supernormal period mentioned by Nahum and Hoff2' and the vulnerable period discussed by Wiggers.
The use of ephedrine was questioned considerably for fear it might precipitate attacks in a heart known to be subject to ventricular arrhythmia. It has generally been considered to be contraindicated ili patients with veiitricular arrhythmias.
The other change in treatment at the tutuing point in this patient's condition was the administration of Aureomycin. This conceivably could have had a role in the patient's improvement if she had had a myocarditis due to an Aureomycin-sensitive organism. We have no basis for such a presumption and we cannot suggest that the drug influenced the cause of the arrhythmia. On the other hand, we cannot be sure it was not of some benefit. It would seem from our experience iii this case and that of others2' that ephedrine is of value in treating certain ventricular arrhythmias causing Stokes-Adams attacks. It is suggested that it is of value in those cases in which the ventricular rate is slow and the general refractory state of the ventricular muscle is decreased. This would include the cases of heart block with venitricular standstill and arrhythmias, and those with slow sinus rhythm with transient attacks of ventricular tachycardia, fibrillation or a combination of these. The rationale for the use of ephedrine is to increase the refractory state of the conduction system and ventricular muscle by increasing the heart rate and thereby prevent the arrhythmia.
The formerly held theoretic objection to this drug in patients subject to transient ventricular arrhythmia apparently is not borne out by clinical experience in this and other patients with slow ventricular rates. SUMMARY 1. A case of Stokes-Adams syndrome has been presented which demonstrates graphically that attacks were due to ventricular tachycardia, ventricular flutter (or prefibrillary tachycardia), and ventricular fibrillation, without heart block or asystole.
2. The underlying etiology is unknown. An abnormally long Q-T interval was present and is unexplained.
3. Large doses of quinidine to the point of intolerable toxicity failed to prevent recurrences. Ephedrine sulfate was given with resulting immediate improvement and no recurrence of the arrhythmia. M, CM VENTRICULAR ARRHYTHMIA AND STOKES-ADAMS SYNDROME 4. It is suggested that ephedrine is of value in treating Stokes-Adams attacks due to ventricular fibrillation and impure ventricular tachycardia in which there is a basic slow rate, as well as those due to heart block and asystole. Apparently the drug acts by speeding the rate thus increasing the refractory state of the conduction system and ventricular muscle. ACKNOWLEDGMENT The author wishes to express his appreciation for the help given by Samuel Bellet, M.D., in the management of this case.
SUMARiO ESPAROL Un caso singular de arritmia ventricular se informa con electrocardiogramas mostrando ataques completos de taquicardia ventricular, undulaci6n ventricular y fibrilacion ventricular. La etiologia se desconoce. Dosis altas de quinidina, hasta el punto de toxicidad aparentaron arrestar la arritmia pero no evitar su reapari-ci6n. Administraci6n de efedrina result6 en inmediata mejoria y sin reaparicion de la arritmia. Se sugiere que la efedrina puede ser de valor en la tratamiento de ataques Stokes-Adams debidos a arritmias ventriculares en que no hay bloque cardiaco pero si una bradicardia subyacente.
